{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Return to MedStarHealth.org
MedStar Health
  • Sign In
  • Conferences
  • RSS
  • Online Courses
  • Learning from Teaching
  • Performance Quality Improvement
  • Contact Us
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
MedStar associates, you will log in to CloudCME with your SiTEL Learning Management System (SITELMS) account on the next screen.

If you are not a MedStar associate, you can log in or create an account on the next screen.

For login assistance, contact the SiTEL Help Center at 1-855-745-1861 (Mon-Fri 8 AM to 5 PM) or at [email protected]
I am a MedStar Associate (login via SiTEL)
I am Not a MedStar Associate
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AAS
  • ACNP
  • BSN
  • BSND
  • BSRT
  • CCT
  • CNM
  • CRNP
  • CRNP, RN
  • CVT
  • DNP
  • DO
  • DPM
  • DPM, MS
  • DPM. MPH
  • DPT
  • FNP
  • JD
  • LCSW-C
  • LICSW
  • LMSW
  • LPN
  • MA
  • MBBS, DTMH
  • MD
  • MD, FACC
  • MD, FACS
  • MD, JD
  • MD, MBA
  • MD, MPH
  • MD, MSc, MBA
  • MD, PhD
  • MD, PhD, MS
  • MGC, CGC
  • MHA
  • MPH
  • MPT
  • MS
  • MS, ATC
  • MS, MPH, CGC
  • MSN
  • MSOT
  • MSOTR/L, CLT
  • MSPH
  • MSW
  • None
  • NP
  • Other
  • OTR
  • PA
  • PA-C
  • PharmD
  • PhD
  • PsyD
  • PT
  • PT, DPT
  • RCES
  • RCIS
  • RD
  • RDN
  • RN
  • RN, BSN
  • RN, BSN, CCRN, CWON
  • RT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Advances in the Management of Prostate, Bladder and Kidney Cancers - 2021


Advances in the Management of Prostate, Bladder and Kidney Cancers - 2021 Banner

  • Overview
  • Faculty
  • Schedule
  • Exhibitors
  • FAQ
Add to Calendar Advances in the Management of Prostate, Bladder and Kidney Cancers - 2021 6/18/2021 11:00:00 AM 6/19/2021 3:00:00 PM America/New_York For More Details: https://medstar.cloud-cme.com/course/courseoverview?EID=8662 Description: MedStar Health is proud to present this blended conference to bring you the most up-to-date comprehensive care and education for kidney, bladder, and prostate. During this meeting you can attend high caliber lectures with questions and discussion time focusing on these three cancer areas. Expert faculty will deliver state-of-the-art lectures that will include treatment approaches, clinical trials, bio... Virtual false MM/DD/YYYY


Date & Location
Friday, June 18, 2021, 11:00 AM - Saturday, June 19, 2021, 3:00 PM, Virtual

Target Audience
Specialties - Medical Oncology, Oncology, Pathology, Radiation Oncology, Radiology, Surgery, Urology

Overview
MedStar Health is proud to present this blended conference to bring you the most up-to-date comprehensive care and education for kidney, bladder, and prostate. During this meeting you can attend high caliber lectures with questions and discussion time focusing on these three cancer areas. Expert faculty will deliver state-of-the-art lectures that will include treatment approaches, clinical trials, biologic and genomic factors and future directions. Kidney and Bladder Cancers will focus on recent advances in the treatment of these diseases and their integration into the multidisciplinary management of patients with early stage, high risk and metastatic disease. Presentations will also discuss emerging controversies and ongoing research aimed at addressing them, as well as the impact of the COVID-19 pandemic. Advances in Prostate Cancer reviews recent advances in the diagnosis and treatment of patients with localized and advanced prostate cancer. Key clinical topics will include the use of biomarkers and modern imaging technologies in the management of early stage prostate cancer as well as advances in the multidisciplinary approach to patients with high-risk, locally advanced, relapsed non-metastatic, and metastatic prostate cancer. Applications of new therapeutic agents, cutting edge radiation technology, combined modality strategies and evolving minimally invasive urologic surgical approaches will also be discussed.

Objectives

At the conclusion of this activity, members of the Healthcare Team will be able to:


  1. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with prostate, kidney and bladder cancers.
  2. Integrate a team-based approach in the care of patients with prostate, kidney and bladder cancers.
  3. Discuss the current treatment algorithm for patients with metastatic clear cell and non-clear cell renal cell carcinoma (RCC).
  4. Describe emerging treatments, endpoints and predictive biomarkers for RCC management.
  5. Describe the evolving role of surgery in the management of patients with all stages of kidney cancer, including the impact of the COVID-19 pandemic.
  6. Discuss the evolving roles of urology and medical oncology in the management of localized bladder cancer.
  7. Describe the role of immunotherapy and novel targeted therapies for upper tract and chemotherapy-refractory carcinoma.
  8. Discuss the recent advances in multi-modality evaluation and management of early stage of prostate cancer.
  9. Discuss the biology and evolving therapeutics for advanced prostate cancer.
  10. Describe symptom management, supportive care, procedural and pharmacological basis of treating prostate and bladder cancers.

Registration
  • Registration is now complimentary for healthcare providers!

    • Physician $150  $0
    • Resident and Fellow $50  $0
    • Physician Assistant $50  $0
    • Nurse Practitioner $50  $0
    • Nurse $50  $0
    • Allied Health Professional $50  $0
    • Industry Professional $200

Accreditation
In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 9.25 Interprofessional Continuing Education (IPCE) credits for learning and change.


Physicians: MedStar Health designates this live activity for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 9.25  ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.


Credits
AMA PRA Category 1 Credits™ Physician (10.00 hours), IPCE (10.00 hours), Non-Physician Member of the Healthcare Team (10.00 hours), Nurse - ANCC (10.00 hours)

Faculty Photos
Piyush K. Agarwal, MD
Head, Bladder Cancer Section, Urologic Oncology Branch
University of Chicago
CHICAGO, IL
Faculty Photos
Michael B. Atkins, MD
Deputy Director, Georgetown Lombardi Comprehensive Cancer Center, William M. Scholl, Staff Physician, Division of Hematology/Oncology, Professor and Vice-Chair Department of Oncology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.
Faculty Photos
Toni K. Choueiri, MD
Director, Lank Center for Genitourinary Oncology; Department of Medical Oncology; Dana-Farber Cancer Institute; The Jerome and Nancy Kohlberg Endowed Chair; Harvard Medical School
Dana Farber Cancer Institute
Westwood, MA
Faculty Photos
Deborah Citrin, MD
Senior Investigator; Head, Section of Translational Radiation Oncology; Radiation Oncology Branch, Center for Cancer Research; National Cancer Institute; National Institutes of Health
National Cancer Institute
Bethesda, MD
Faculty Photos
William L. Dahut, MD
CCR Scientific Director for Clinical Research, NCI Clinical Director Head, Prostate Cancer Clinical Research Section
Center for Cancer Research, National Cancer Institute
Bethesda, MD
Faculty Photos
Robert Dreicer, MD, MS, MACP
Deputy Director, Section Head Medical Oncology; Professor, Medicine and Urology
UVA Cancer Center, University of Virginia
Earlysville, VA
Faculty Photos
Kellie Gardner, NP
Nurse Practitioner
Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital
Washington, D.C.
Faculty Photos
Jim C. Hu, MD, MPH
Attending Urologist, Ronald P. Lynch Professor of Urologic Oncology, Director of the LeFrak Center for Robotic Surgery
New York Presbyterian/Weill Cornell
New York, NY
Faculty Photos
Burles A Johnson III, MD, PhD
Instructor of Oncology
Sidney Kimmel Comprehensive Cancer Center, Greenberg Bladder Cancer Institute, Johns Hopkins University
Baltimore, MD
Faculty Photos
William G. Kaelin Jr., MD
Sidney Farber Professor of Medicine, Investigator, Howard Hughes Medical Institute
Dana-Farber Cancer Institute, Harvard Medical School
Boston, MA
Faculty Photos
Fatima Karzai, MD
Deputy Clinical Director, National Cancer Institute, Senior Clinician
Genitourinary Malignancies Branch, National Institutes of Health
Bethesda, MD
Faculty Photos
Keith J. Kowalczyk, MD
Physician Executive Director, Chair, Department of Urology, Chair, MedStar Robotic Surgery Service Line
MedStar Health Urology, MedStar Georgetown University Hospital, Georgetown University Medical Center
Washington, D.C.
Faculty Photos
Ross E. Krasnow, MD
Staff Physician, Urologic Oncologist, Assistant Professor, Urology
MedStar Washington Hospital Center, Georgetown University School of Medicine
Washington, D.C.
Faculty Photos
Young Kwok, MD
Professor, Radiation Oncology
Maryland Proton Treatment Center, University of Maryland Medical Center, University of Maryland School of Medicine
Baltimore, MD
Faculty Photos
Paul D. Leger, MD
Medical Oncologist
MedStar Georgetown University Hospital
Washington, D.C.
Faculty Photos
Frank I. Lin, MD
Investigator, Molecular Imaging Branch, NIH Lasker Clinical Research, Scholar, Head, Targeted Radionuclide Therapy Section
National Cancer Institute
Bethesda, MD
Faculty Photos
Ravi A. Madan, MD
Clinical Director, Genitourinary Malignancies Branch
National Cancer Institute
Bethesda, MD
Faculty Photos
David F. McDermott, MD
Chief, Medical Oncology, Leader, Kidney Cancer Program, Professor, Medicine
Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Harvard Medical School
Boston, MA
Faculty Photos
Channing J. Paller, MD
Medical Oncologist; Associate Professor, Oncology
Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University
Chevy Chase, MD
Faculty Photos
George K. Philips, MD
Vice Chair, Department of Medicine, Staff Physician, Hematology/Oncology
MedStar Georgetown University Hospital, Georgetown Lombardi Comprehensive Cancer Center
Washington, DC
Faculty Photos
Peter A. Pinto, MD
Head, Prostate Cancer Section, Director, Fellowship Program Urologic Oncology Branch
National Cancer Institute, National Institutes of Health
Bethesda, MD
Faculty Photos
Suthee Rapisuwon, MD
Attending Physician, Hematology-Oncology, Assistant Professor, Oncology
MedStar Georgetown University Hospital, Georgetown University School of Medicine
Washington, D.C.
Faculty Photos
Jonathan E. Rosenberg, MD
Chief, Genitourinary Oncology Service; Enno Ercklentz Endowed Chair Attending Physician
Memorial Sloan Kettering Cancer Center; Weill Cornell Medical College
New York, NY
Carolyn Schweitzer, BSN
MedStar Georgetown University Hospital
Washington, DC
Faculty Photos
Daniel Spratt, MD
Vincent Smith Professor and Chair, Department of Radiation Oncology
University Hospitals, Seidman Cancer Center, Case Western Reserve University School of Medicine
Cleveland, OH
Faculty Photos
Robert G. Uzzo, MD, MBA
Chairman, Department of Surgery; G. Willing "Wing" Pepper Chair in Cancer Research; Professor, Department of Surgery; Professor of Surgery, Temple University Health System; Adjunct Professor of Bioengineering, Temple University College of Engineering
Fox Chase Cancer Center
Philadelphia, PA

Friday, June 18, 2021
Visit the Exhibitors
11:00AM - 12:00PM
Welcome Remarks
12:00PM - 12:10PM
Ross E. Krasnow, MD
Keynote: Progress in Prostate Cancer Management in 2020
12:10PM - 12:45PM
William L. Dahut, MD
Keynote Questions and Discussion
12:45PM - 1:00PM
Ross E. Krasnow, MD (Moderator)
William L. Dahut, MD
Session I: Management of Early-Stage Prostate Cancer
1:00PM - 2:20PM
Keith J. Kowalczyk, MD
Ross E. Krasnow, MD
Retzius-Sparing Robot Assisted Radical Prostatectomy: Evolution and Outcomes
1:05PM - 1:20PM
Keith J. Kowalczyk, MD
Emerging Role of Focal Therapy for Localized Prostate Cancer
1:20PM - 1:35PM
Jim C. Hu, MD, MPH
Frontiers in Imaging in the Pretreatment Setting
1:35PM - 1:50PM
Peter A. Pinto, MD
Prostate Cancer Health Disparities
1:50PM - 2:00PM
Paul D. Leger, MD
Questions and Discussion
2:00PM - 2:20PM
Jim C. Hu, MD, MPH
Keith J. Kowalczyk, MD (Moderator)
Ross E. Krasnow, MD (Moderator)
Paul D. Leger, MD
Peter A. Pinto, MD
Break and Visit the Exhibits
2:20PM - 2:35PM
Non-CE Symposium: ERLEADA: For the Treatment of Patients with nmCRPC and mCSPC
2:35PM - 3:35PM

Speaker: Nancy Dawson, MD

Sponsored by Janssen Biotech


SESSION II: Management of High-Risk and Advanced Prostate Cancer
3:35PM - 4:45PM
George K. Philips, MD
Personalized Approach to Postoperative Radiation and Hormonal Therapy in Men with Biochemical Recurrence Following Prostatectomy
3:40PM - 3:55PM
Daniel Spratt, MD
Radiation for Biochemically-Recurrent and Oligometastatic Prostate Cancer
3:55PM - 4:10PM
Young Kwok, MD
Updates in the Management of Metastatic Hormone Sensitive Prostate Cancer
4:10PM - 4:25PM
Robert Dreicer, MD, MS, MACP
Questions and Discussion
4:25PM - 4:45PM
George K. Philips, MD (Moderator)
Young Kwok, MD
Daniel Spratt, MD
Robert Dreicer, MD, MS, MACP
Break and Visit the Exhibits
4:45PM - 5:00PM
Session III: Management of Metastatic Castration Resistant Prostate Cancer
5:00PM - 6:25PM
Young Kwok, MD
Paul D. Leger, MD
Therapeutic Potential of PARP Inhibition in Prostate Cancer
5:05PM - 5:20PM
Channing J. Paller, MD
PSMA-Targeted Radionuclide Therapy for Advanced Prostate Cancer
5:20PM - 5:35PM
Frank I. Lin, MD
New Immunotherapeutic Approaches to Advanced Prostate Cancer
5:35PM - 5:50PM
Ravi A. Madan, MD
New Biology, Novel Approaches and Targeted Therapies for Prostate Cancer
5:50PM - 6:05PM
Fatima Karzai, MD
Questions and Discussion
6:05PM - 6:25PM
Fatima Karzai, MD
Young Kwok, MD (Moderator)
Paul D. Leger, MD (Moderator)
Ravi A. Madan, MD
Channing J. Paller, MD
Frank I. Lin, MD
Closing Remarks
6:25PM - 6:30PM
Networking Reception with Exhibitors
6:30PM - 7:30PM
Saturday, June 19, 2021
Visit the Exhibits
8:00AM - 9:00AM
Welcome Remarks
9:00AM - 9:10AM
Michael B. Atkins, MD
Session IV: Recent Advances in High Risk and Metastatic Kidney Cancer Treatment
9:10AM - 11:15AM
Michael B. Atkins, MD
Update on the Surgical Management of RCC and the Impact of COVID-19 Pandemic
9:10AM - 9:30AM
Robert G. Uzzo, MD, MBA
Update on Systemic Therapy for Metastatic ccRCC
9:30AM - 9:50AM
Michael B. Atkins, MD
Update on the Treatment of nccRCC
9:50AM - 10:10AM
Toni K. Choueiri, MD
Novel Endpoints and Predictive Biomarkers for RCC
10:10AM - 10:30AM
David F. McDermott, MD
Keynote Lecture: Targeting the HIF-2-VEGF Axis in RCC
10:30AM - 11:00AM
William G. Kaelin Jr., MD
Questions and Discussion
11:00AM - 11:15AM
Michael B. Atkins, MD (Moderator)
Toni K. Choueiri, MD
David F. McDermott, MD
William G. Kaelin Jr., MD
Robert G. Uzzo, MD, MBA
Break and Visit the Exhibits
11:15AM - 11:30AM
Session V: Bladder Cancer
11:30AM - 1:50PM
Suthee Rapisuwon, MD
Novel Approaches to Improve Outcomes in Non-Muscle Invasive Urothelial Carcinoma of the Bladder
11:31AM - 11:50AM
Piyush K. Agarwal, MD
Organ Sparing Cystectomy
11:50AM - 12:10PM
Ross E. Krasnow, MD
Evolving Role of Immunotherapy and Targeted Therapies in the Systemic Management of Urothelial Carcinoma
12:10PM - 12:30PM
Burles A Johnson III, MD, PhD
Radio-sensitization Strategies and Bladder Preservation
12:30PM - 12:50PM
Deborah Citrin, MD
Updates in Systemic Therapy for Bladder Cancers
12:50PM - 1:10PM
Jonathan E. Rosenberg, MD
Upper Tract Urothelial Carcinoma; Unique Genetics, Biology and Evolving Therapeutics
1:10PM - 1:30PM
Suthee Rapisuwon, MD
Questions and Discussion
1:30PM - 1:50PM
Piyush K. Agarwal, MD
Deborah Citrin, MD
Ross E. Krasnow, MD
Suthee Rapisuwon, MD
Jonathan E. Rosenberg, MD
Burles A Johnson III, MD, PhD
Closing Remarks
1:50PM - 1:55PM
George K. Philips, MD
Adjourn
1:55PM - 2:00PM
Networking Reception with Exhibitors
2:00PM - 3:00PM

If you are interested in supporting the program, please contact Ada Guo, [email protected].

WHERE DOES THE CONFERENCE TAKE PLACE?
This virtual event takes place completely online. The event uses a virtual environment that allows attendees to view lectures, submit questions to faculty, and connect with other attendees.

DO I HAVE TO ATTEND THE ENTIRE CONFERENCE?
At the end of the conference, you will receive a survey to attest to the number of credit hours you participated in. Please only claim credit that correlates with the number of hours you attended.

WHAT ABOUT CAMERA AND MIC ACCESS?
When you first sign into the virtual platform you will be asked to grant access to your camera and microphone. This is to enable these features should you wish to connect with other attendees over video chat. We will automatically mute you and have your camera off during general session lectures.

WHAT TECHNOLOGY DO I NEED?
You will need a computer or a device such as a laptop, desktop, or tablet. The website is not accessible via phone. You are not required to have a camera or mic capability to listen to the lectures or submit questions to the panel.

Please use a preferred browser such Chrome, Firefox or Safari to participate during the conference. The virtual conference is not accessible over Internet Explorer.

HOW CAN I GET TO THE CONFERENCE?
Registered attendees will receive a link via email to the conference virtual platform OnAir about a week before the event. The link will be sent to the email address you registered with and is how you will access all the conference content. You will use the same link to access the platform during the conference dates and to review recorded presentations after the event.

WHAT IF I DON'T RECEIVE THE LINK?
Contact [email protected] for assistance.

CAN I SHARE THIS LINK WITH OTHERS?
Just like an in-person meeting, registrations should not be shared. The registration provides a single sign-on secure experience for the user. Please note that recordings or downloaded conference material of any kind that are accessed on the platform should not be shared.

WHEN WILL SESSION MATERIAL BE AVAILABLE?
PDF copies of the presentations will be available for download on the session page from those presenters who gave consent to share. These are accessible after the conference date for up to 3 months.

CAN I CHAT WITH OTHERS DURING THE CONFERENCE?
YES! In each session, there is a chat feature that allows you to send messages to others in the session. There is also the Networking Hub where you can message other attendees, faculty, and industry directly with chat or video connections.

I HAVE A QUESTION FOR THE SPEAKER
In each session, there is a chatbox to the right of the screen you can enter in a question for the panel. Our team will collect questions for the moderator to be asked during panel discussion time.

WILL LIVE CONTENT BE AVAILABLE AFTER THE EVENT?
Live content will be recorded, subject to speaker permission, and posted on platform for on-demand viewing. You will continue to have access to session content and exhibit hall until December 31, 2021.

I NEED HELP!
Before the conference date please contact [email protected] for or (833) 731-1273 with any questions.

On the days of the conference, while you are participating on the virtual platform our staff is ready to assist you. There is an orange headset icon in the top right of your screen. This will connect you to a member of our support team.

Contact Us

MedStar Health, Department of Continuing Professional Education
[email protected]
CE.MedStarHealth.org